|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Immunoglobulin domain
|
 |
|
Title:
|
 |
Complex between the pryspry domain of trim21 and igg fc
|
|
Structure:
|
 |
Ig gamma-1 chain c. Chain: a, d. Fragment: residues 120-326. Synonym: lj1. Engineered: yes. 52 kda ro protein. Chain: b, e. Fragment: residues 287-465. Synonym: lj1, sjoegren syndrome type a antigen, ss-a, ro, 52 kda
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Expressed in: escherichia coli. Expression_system_taxid: 562. Expression_system_taxid: 562
|
|
Resolution:
|
 |
|
2.35Å
|
R-factor:
|
0.217
|
R-free:
|
0.253
|
|
|
Authors:
|
 |
L.C.James,A.H.Keeble,D.A.Rhodes,J.Trowsdale
|
Key ref:
|
 |
L.C.James
et al.
(2007).
Structural basis for PRYSPRY-mediated tripartite motif (TRIM) protein function.
Proc Natl Acad Sci U S A,
104,
6200-6205.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
30-Jun-06
|
Release date:
|
27-Mar-07
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
Chains B, E:
E.C.2.3.2.27
- RING-type E3 ubiquitin transferase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-cysteine + N6- ubiquitinyl-[acceptor protein]-L-lysine
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Proc Natl Acad Sci U S A
104:6200-6205
(2007)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structural basis for PRYSPRY-mediated tripartite motif (TRIM) protein function.
|
|
L.C.James,
A.H.Keeble,
Z.Khan,
D.A.Rhodes,
J.Trowsdale.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The human tripartite motif (TRIM) family comprises 70 members, including HIV
restriction factor TRIM5alpha and disease-associated proteins TRIM20 (pyrin) and
TRIM21. TRIM proteins have conserved domain architecture but diverse cellular
roles. Here, we describe how the C-terminal PRYSPRY domain mediates diverse TRIM
functions. The crystal structure of TRIM21 PRYSPRY in complex with its target
IgG Fc reveals a canonical binding interface comprised of two discrete pockets
formed by antibody-like variable loops. Alanine scanning of this interface has
identified the hot-spot residues that control TRIM21 binding to Fc; the same
hot-spots control HIV/murine leukemia virus restriction by TRIM5alpha and
mediate severe familial Mediterranean fever in TRIM20/pyrin. Characterization of
the IgG binding site for TRIM21 PRYSPRY reveals TRIM21 as a superantigen
analogous to bacterial protein A and suggests that an antibody bipolar bridging
mechanism may contribute to the pathogenic accumulation of anti-TRIM21
autoantibody immune complex in autoimmune disease.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
A.K.Kar,
Y.Mao,
G.Bird,
L.Walensky,
and
J.Sodroski
(2011).
Characterization of a core fragment of the rhesus monkey TRIM5α protein.
|
| |
BMC Biochem,
12,
1.
|
 |
|
|
|
|
 |
F.W.McNab,
R.Rajsbaum,
J.P.Stoye,
and
A.O'Garra
(2011).
Tripartite-motif proteins and innate immune regulation.
|
| |
Curr Opin Immunol,
23,
46-56.
|
 |
|
|
|
|
 |
G.Zhao,
D.Ke,
T.Vu,
J.Ahn,
V.B.Shah,
R.Yang,
C.Aiken,
L.M.Charlton,
A.M.Gronenborn,
and
P.Zhang
(2011).
Rhesus TRIM5α disrupts the HIV-1 capsid at the inter-hexamer interfaces.
|
| |
PLoS Pathog,
7,
e1002009.
|
 |
|
|
|
|
 |
P.D.Griffiths,
and
R.S.Milne
(2011).
Intracellular neutralisation of adenovirus by antibody.
|
| |
Rev Med Virol,
21,
1-2.
|
 |
|
|
|
|
 |
S.Ohkura,
D.C.Goldstone,
M.W.Yap,
K.Holden-Dye,
I.A.Taylor,
and
J.P.Stoye
(2011).
Novel escape mutants suggest an extensive TRIM5α binding site spanning the entire outer surface of the murine leukemia virus capsid protein.
|
| |
PLoS Pathog,
7,
e1002011.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
D.L.Mallery,
W.A.McEwan,
S.R.Bidgood,
G.J.Towers,
C.M.Johnson,
and
L.C.James
(2010).
Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21).
|
| |
Proc Natl Acad Sci U S A,
107,
19985-19990.
|
 |
|
|
|
|
 |
P.D.Burbelo,
K.H.Ching,
B.L.Han,
E.R.Bush,
W.H.Reeves,
and
M.J.Iadarola
(2010).
Extraordinary antigenicity of the human Ro52 autoantigen.
|
| |
Am J Transl Res,
2,
145-155.
|
 |
|
|
|
|
 |
P.Filippakopoulos,
A.Low,
T.D.Sharpe,
J.Uppenberg,
S.Yao,
Z.Kuang,
P.Savitsky,
R.S.Lewis,
S.E.Nicholson,
R.S.Norton,
and
A.N.Bullock
(2010).
Structural basis for Par-4 recognition by the SPRY domain- and SOCS box-containing proteins SPSB1, SPSB2, and SPSB4.
|
| |
J Mol Biol,
401,
389-402.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
Q.T.Pham,
A.Bouchard,
M.G.Grütter,
and
L.Berthoux
(2010).
Generation of human TRIM5alpha mutants with high HIV-1 restriction activity.
|
| |
Gene Ther,
17,
859-871.
|
 |
|
|
|
|
 |
A.P.Mascarenhas,
and
K.Musier-Forsyth
(2009).
The capsid protein of human immunodeficiency virus: interactions of HIV-1 capsid with host protein factors.
|
| |
FEBS J,
276,
6118-6127.
|
 |
|
|
|
|
 |
J.Jeong,
A.U.Rao,
J.Xu,
S.L.Ogg,
Y.Hathout,
C.Fenselau,
and
I.H.Mather
(2009).
The PRY/SPRY/B30.2 domain of butyrophilin 1A1 (BTN1A1) binds to xanthine oxidoreductase: implications for the function of BTN1A1 in the mammary gland and other tissues.
|
| |
J Biol Chem,
284,
22444-22456.
|
 |
|
|
|
|
 |
J.N.Torimiro,
H.Javanbakht,
F.Diaz-Griffero,
J.Kim,
J.K.Carr,
M.Carrington,
J.Sawitzke,
D.S.Burke,
N.D.Wolfe,
M.Dean,
and
J.Sodroski
(2009).
A rare null allele potentially encoding a dominant-negative TRIM5alpha protein in Baka pygmies.
|
| |
Virology,
391,
140-147.
|
 |
|
|
|
|
 |
L.M.van der Aa,
J.P.Levraud,
M.Yahmi,
E.Lauret,
V.Briolat,
P.Herbomel,
A.Benmansour,
and
P.Boudinot
(2009).
A large new subset of TRIM genes highly diversified by duplication and positive selection in teleost fish.
|
| |
BMC Biol,
7,
7.
|
 |
|
|
|
|
 |
R.Yoshimi,
T.H.Chang,
H.Wang,
T.Atsumi,
H.C.Morse,
and
K.Ozato
(2009).
Gene disruption study reveals a nonredundant role for TRIM21/Ro52 in NF-kappaB-dependent cytokine expression in fibroblasts.
|
| |
J Immunol,
182,
7527-7538.
|
 |
|
|
|
|
 |
S.Sebastian,
C.Grütter,
C.S.de Castillia,
T.Pertel,
S.Olivari,
M.G.Grütter,
and
J.Luban
(2009).
An invariant surface patch on the TRIM5alpha PRYSPRY domain is required for retroviral restriction but dispensable for capsid binding.
|
| |
J Virol,
83,
3365-3373.
|
 |
|
|
|
|
 |
S.U.Tareen,
S.L.Sawyer,
H.S.Malik,
and
M.Emerman
(2009).
An expanded clade of rodent Trim5 genes.
|
| |
Virology,
385,
473-483.
|
 |
|
|
|
|
 |
Y.Cui,
H.S.Tae,
N.C.Norris,
Y.Karunasekara,
P.Pouliquin,
P.G.Board,
A.F.Dulhunty,
and
M.G.Casarotto
(2009).
A dihydropyridine receptor alpha1s loop region critical for skeletal muscle contraction is intrinsically unstructured and binds to a SPRY domain of the type 1 ryanodine receptor.
|
| |
Int J Biochem Cell Biol,
41,
677-686.
|
 |
|
|
|
|
 |
A.H.Keeble,
Z.Khan,
A.Forster,
and
L.C.James
(2008).
TRIM21 is an IgG receptor that is structurally, thermodynamically, and kinetically conserved.
|
| |
Proc Natl Acad Sci U S A,
105,
6045-6050.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
A.K.Kar,
F.Diaz-Griffero,
Y.Li,
X.Li,
and
J.Sodroski
(2008).
Biochemical and biophysical characterization of a chimeric TRIM21-TRIM5alpha protein.
|
| |
J Virol,
82,
11669-11681.
|
 |
|
|
|
|
 |
C.R.Langelier,
V.Sandrin,
D.M.Eckert,
D.E.Christensen,
V.Chandrasekaran,
S.L.Alam,
C.Aiken,
J.C.Olsen,
A.K.Kar,
J.G.Sodroski,
and
W.I.Sundquist
(2008).
Biochemical characterization of a recombinant TRIM5alpha protein that restricts human immunodeficiency virus type 1 replication.
|
| |
J Virol,
82,
11682-11694.
|
 |
|
|
|
|
 |
E.Fragouli,
E.Eliopoulos,
E.Petraki,
P.Sidiropoulos,
I.Aksentijevich,
E.Galanakis,
H.Kritikos,
A.Repa,
G.Fragiadakis,
D.Boumpas,
and
G.N.Goulielmos
(2008).
Familial Mediterranean Fever in Crete: a genetic and structural biological approach in a population of 'intermediate risk'.
|
| |
Clin Genet,
73,
152-159.
|
 |
|
|
|
|
 |
J.G.Ryan,
and
R.Goldbach-Mansky
(2008).
The spectrum of autoinflammatory diseases: recent bench to bedside observations.
|
| |
Curr Opin Rheumatol,
20,
66-75.
|
 |
|
|
|
|
 |
K.Ozato,
D.M.Shin,
T.H.Chang,
and
H.C.Morse
(2008).
TRIM family proteins and their emerging roles in innate immunity.
|
| |
Nat Rev Immunol,
8,
849-860.
|
 |
|
|
|
|
 |
M.W.Richardson,
R.G.Carroll,
M.Stremlau,
N.Korokhov,
L.M.Humeau,
G.Silvestri,
J.Sodroski,
and
J.L.Riley
(2008).
Mode of transmission affects the sensitivity of human immunodeficiency virus type 1 to restriction by rhesus TRIM5alpha.
|
| |
J Virol,
82,
11117-11128.
|
 |
|
|
|
|
 |
R.L.Glaser,
and
R.Goldbach-Mansky
(2008).
The spectrum of monogenic autoinflammatory syndromes: understanding disease mechanisms and use of targeted therapies.
|
| |
Curr Allergy Asthma Rep,
8,
288-298.
|
 |
|
|
|
|
 |
G.J.Towers
(2007).
The control of viral infection by tripartite motif proteins and cyclophilin A.
|
| |
Retrovirology,
4,
40.
|
 |
|
|
|
|
 |
P.A.Ramsland,
N.Willoughby,
H.M.Trist,
W.Farrugia,
P.M.Hogarth,
J.D.Fraser,
and
B.D.Wines
(2007).
Structural basis for evasion of IgA immunity by Staphylococcus aureus revealed in the complex of SSL7 with Fc of human IgA1.
|
| |
Proc Natl Acad Sci U S A,
104,
15051-15056.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
P.V.Maillard,
S.Reynard,
F.Serhan,
P.Turelli,
and
D.Trono
(2007).
Interfering residues narrow the spectrum of MLV restriction by human TRIM5alpha.
|
| |
PLoS Pathog,
3,
e200.
|
 |
|
|
|
|
 |
S.L.Sawyer,
M.Emerman,
and
H.S.Malik
(2007).
Discordant evolution of the adjacent antiretroviral genes TRIM22 and TRIM5 in mammals.
|
| |
PLoS Pathog,
3,
e197.
|
 |
|
|
|
|
 |
T.Schaller,
S.Hué,
and
G.J.Towers
(2007).
An active TRIM5 protein in rabbits indicates a common antiviral ancestor for mammalian TRIM5 proteins.
|
| |
J Virol,
81,
11713-11721.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |